Survival according to the assigned cytorabin treatment. OS (A-B) and EFS (C-D) are presented according to the cytarabine dose given. In the initial part of the protocol, 406 AML patients were randomized between yes and no G-CSF, whereas in the final part of the protocol, all 511 AML patients received conventional-dose cytarabine.